Thomas Milner

Thomas Milner, Ph.D. is one of the early investigators in photomedicine. Dr. Milner is a pioneer in introducing novel endogenous contrast mechanisms for the optical imaging of tissue. Dr. Milner is an inventor of 55 U.S. patents and five international patents that have been licensed to six companies. He developed and demonstrated novel catheters for intravascular imaging, is a co-inventor of the MasSpec Pen that has been featured worldwide, and is a co-founder of CardioSpectra and Dermalucent. His patent royalties to university IP Owners/Licensees have returned over $100 million, and he has authored 190 peer-reviewed articles and eight book chapters.